ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

New Cyclotron Delivered To University of Maryland, Instigating D.C.-Area Proton Radiation Competition

June 20, 2014

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013